Vitafoods Insights Podcast

Developing new solutions to support performance and address inflammation can mean going beyond ‘popular’ ingredients into unique offerings.  While there is a great amount of consumer and market interest in cannabidiol (CBD), there remain market and regulatory constraints, as well as questions on its efficacy for addressing certain conditions. However, there are other ingredient options that may be better suited for addressing issues such as recovery, pain, sleep, and immune health. Palmitoylethanolamide (PEA) is one such ingredient that has scientifically supported efficacy in these areas, and may serve as an alternative to CBD. Gencor Pacific offers https://www.gencorpacific.com/ingredients/levagen (Levagen®+,) a bioavailable PEA powered by LipiSperse® technology. In this podcast, sponsored by Gencor Pacific, you’ll hear more about:  The legal, safety and efficacy challenges of CBD How the endocannabinoid system functions and its benefits Functional impacts of PEA and its similarity to CBD Benefits